

Cover Story
Free
Duke University would have avoided embarrassment, a misconduct investigation and a lawsuit, had its top administrators paid closer attention to a thoughtful report by a medical student who saw problems in the lab of the disgraced scientist Anil Potti.
In Brief


Drugs & Targets


Trending Stories
- Trump backs off the 100% pharma tariffs ultimatum
- Latinx oncology leaders talk about the impact of federal policy on cancer outcomes in Latinx communities
- KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill
- ASCO and Google Cloud set forth a vision for using AI to modernize health care and advance oncology
- Study finds no correlation between cancer burden in catchment areas and cancer centers’ CCSG funding
- Under the lens: Taking a close look at the NIH and FDA declarations on animal-based research